Eligibility, Compliance and Persistence of Sequential Therapy with Aromatase Inhibitors following 2–3 Years of Tamoxifen in Endocrine Adjuvant Breast Cancer Therapy

By  

Oncology, Vol. 81, Iss. 3-4, 2011-10 ,pp. : 151-157

Karger

Access to resources Recommend Favorite

Prescription Pattern of Aromatase Inhibitors for the Adjuvant Therapy of Breast Cancer in Germany – Results of the Second Survey Among Gynaecologists and Medical Oncologists

By  

Oncology Research and Treatment, Vol. 31, Iss. 1-2, 2008-01 ,pp. : 19-25

Karger

Access to resources Recommend Favorite

Aromatase inhibitors, tamoxifen, and endometrial cancer in breast cancer survivors

By  

CANCER, Vol. 121, Iss. 13, 2015-07 ,pp. : 2147-2155

John Wiley & Sons Inc

Access to resources Recommend Favorite

Design, synthesis, and PASS-assisted evaluation of novel 2-substituted benzimidazole derivatives as potent anthelmintics

By Garg Kamalpriya   Bansal Yogita   Bansal Gulshan   Goel R.  

Medicinal Chemistry Research, Vol. 23, Iss. 5, 2014-05 ,pp. : 2690-2697

Springer Publishing Company

Access to resources Recommend Favorite

Synthesis and preliminary evaluation of 2-substituted-1,3-benzoxazole and 3-[(3-substituted)propyl]-1,3-benzoxazol-2(3 H )-one derivatives as potent anticancer agents

By Murty M.  

Medicinal Chemistry Research, Vol. 20, Iss. 5, 2011-06 ,pp. : 576-586

Springer Publishing Company

Access to resources Recommend Favorite